Thomas Meier

Patrimonio netto: 141 664 $ in data 30/04/2024

62 anni

Health Technology

Consumer Services

Commercial Services

Posizioni attive di Thomas Meier

Società	Posizione	Inizio	Fine
SANTHERA PHARMACEUTICALS HOLDING AG	Presidente	30/06/2022	-
	Fondatore	07/09/2004	-
	Direttore/Membro del Consiglio	04/04/2017	30/06/2022
	Amministratore Delegato	11/10/2011	01/12/2019
	Contatto Relazioni con gli Investitori	-	-
	Public Communications Contact	-	-
ONCONETIX, INC.	Direttore/Membro del Consiglio	06/02/2024	-
Novaremed AG Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel.	Direttore/Membro del Consiglio	01/05/2020	-
Viopas Venture Consulting GmbH Viopas Venture Consulting GmbH Investment ManagersFinance Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland.	Corporate Officer/Principal	-	-
Visgenx, Inc. Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA.	Direttore/Membro del Consiglio	01/01/2022	-

Società	Posizione	Inizio	Fine
PharmaBiome AG PharmaBiome AG Miscellaneous Commercial ServicesCommercial Services PharmaBiome AG specializes in isolation, characterization, and technology of novel intestinal microbes. It develops and produces microbiome therapies to treat intestinal diseases. The company was founded by Tomas de Wouters and is headquartered in Zurich, Switzerland.	Presidente	01/07/2020	01/01/2021
MyoContract AG	Amministratore Delegato	01/01/2000	01/01/2004
MyoContract AG	Fondatore	01/01/2000	01/01/2004

University of Basel

Doctorate Degree

Distribuzione geografica

Svizzera	7
Stati Uniti	3

Posizioni

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
SANTHERA PHARMACEUTICALS HOLDING AG	Health Technology
ONCONETIX, INC.	Health Technology

Aziende private	5
MyoContract AG	Health Technology
Novaremed AG Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel.	Health Technology
PharmaBiome AG PharmaBiome AG Miscellaneous Commercial ServicesCommercial Services PharmaBiome AG specializes in isolation, characterization, and technology of novel intestinal microbes. It develops and produces microbiome therapies to treat intestinal diseases. The company was founded by Tomas de Wouters and is headquartered in Zurich, Switzerland.	Commercial Services
Viopas Venture Consulting GmbH Viopas Venture Consulting GmbH Investment ManagersFinance Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland.	Finance
Visgenx, Inc. Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA.	Health Technology